palmidrol

peroxisome proliferator activated receptor alpha ; Mus musculus







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35469820 Palmitoylethanolamide ameliorates neuroinflammation via modulating PPAR-α to promote the functional outcome after intracerebral hemorrhage. 2022 Jun 11 1
2 33668991 The Nutraceutical N-Palmitoylethanolamide (PEA) Reveals Widespread Molecular Effects Unmasking New Therapeutic Targets in Murine Varicocele. 2021 Feb 25 2
3 33808491 Vitamin D Deficiency Induces Chronic Pain and Microglial Phenotypic Changes in Mice. 2021 Mar 30 2
4 33986036 Antinociceptive Profile of ARN19702, (2-Ethylsulfonylphenyl)-[(2S)-4-(6-fluoro-1,3-benzothiazol-2-yl)-2-methylpiperazin-1-yl]methanone, a Novel Orally Active N-Acylethanolamine Acid Amidase Inhibitor, in Animal Models. 2021 Aug 2
5 31914699 Palmitoylethanolamide counteracts hepatic metabolic inflexibility modulating mitochondrial function and efficiency in diet-induced obese mice. 2020 Jan 2
6 32298438 PPARα-Dependent Effects of Palmitoylethanolamide Against Retinal Neovascularization and Fibrosis. 2020 Apr 9 1
7 32634582 N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis. 2020 Oct 2
8 30955840 Stimulation of Peroxisome Proliferator-Activated Receptor-α by N-Palmitoylethanolamine Engages Allopregnanolone Biosynthesis to Modulate Emotional Behavior. 2019 Jun 15 3
9 32047441 N-Palmitoylethanolamine Maintains Local Lipid Homeostasis to Relieve Sleep Deprivation-Induced Dry Eye Syndrome. 2019 1
10 29054595 The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis. 2018 Mar 1
11 30193877 Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms. 2018 Nov 2
12 30354245 Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation. 2018 Nov 1
13 27616549 Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence. 2016 Nov 2
14 27720681 Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis. 2016 Nov 15 4
15 25205418 Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent. 2015 Jan 4
16 25384424 N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis. 2015 Feb 3
17 24818658 Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels. 2014 Sep 2
18 23218523 Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models. 2013 Mar 4
19 23533304 Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism. 2013 1
20 22912680 Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease. 2012 1
21 22916199 Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds. 2012 1
22 22972997 Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons. 2012 Sep 12 5
23 20221904 Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-α. 2011 Feb 1
24 19386271 Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia. 2009 Jun 24 2
25 19926854 Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. 2009 Dec 8 4
26 18367664 Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. 2008 Jul 2
27 17565008 Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice. 2007 Sep 3